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Abstract: 
 
Aims:  Based on indirect methods, it has been suggested that both L- and T-type Ca2+ 
channels mediate signalling in the renal afferent arteriole and that T-type Ca channels are 
involved in signalling in the efferent arteriole.  However, Ca2+ currents have never been 
studied in these two vessels. Our study was initiated to directly determine the type of Ca2+ 
channels in these vessels for the first time, using patch clamp.  
Methods and Results: Native myocytes were obtained from individually isolated rat renal 
afferent and efferent arterioles and from rat tail arteries (TA). TA myocytes, which possess 
both L- and T-type Ca2+ currents, served as a positive control. Inward Ca2+ and Ba2+ currents 
(ICa and IBa) were measured in 1.5 mmol/L Ca2+ and 10 mmol/L Ba2+, respectively, using the 
whole-cell configuration.  By exploiting known differences in activation and inactivation 
characteristics and differing sensitivities to nifedipine and kurtoxin, the presence of both L- 
and T-type Ca2+ channels in TA myocytes were readily demonstrated. Afferent arteriolar 
myocytes exhibited relatively large ICa densities (-2.0±0.2 pA/pF) in physiologic Ca and the 
IBa was 3.6 fold greater. These currents were blocked by nifedipine, but not by kurtoxin and 
did not exhibit the activation and inactivation characteristics of T-type Ca channels.  Efferent 
arteriolar myocytes did not exhibit a discernable voltage-activated ICa in physiologic Ca2+.   
Conclusions: Our findings support the physiologic role of L-type Ca2+ channels in the 
afferent, but not efferent, arteriole, but do not support the premise that functional T-type Ca2+ 
channels are present in either vessel. 
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1. Introduction 
 
The renal afferent and efferent arterioles regulate the inflow and outflow resistances of the 
glomerulus and thereby regulate the pressure within the intervening glomerular capillaries 
(PGC).  Afferent arteriolar constriction reduces PGC and, for example, prevents the 
transmission of systemic hypertension to the glomerulus.1  A selective efferent 
vasoconstriction increases PGC and is essential in preserving glomerular filtration rate (GFR) 
when renal perfusion is compromised.2  Considering their differing roles and the physiologic 
need for independent regulation, it is not surprising that these two vessels have quite distinct 
regulatory mechanisms.  A key difference involves the types of Ca2+ entry mechanisms 
present in each vessel. 
 
Early studies examining the effects of Ca2+ channel blocking agents on renal hemodynamics 
suggested that such agents act selectively on pre-glomerular resistance, increasing PGC and 
GFR.3  This premise was confirmed as diverse approaches, developed to directly assess the 
effects of these agents on the renal microcirculation, demonstrated a preferential dilation of 
the afferent arteriole, and no effect on the efferent arteriole.4,5  Indeed, the efferent arteriole 
appears to be unique, in that not only is this vessel insensitive to L-type Ca2+ blockers, but, 
with rare exceptions,6,7 depolarization does not cause vasoconstriction or Ca2+ entry.8-10  
Similarly, hyperpolarization, which attenuates afferent arteriolar vasoconstriction, presumably 
by reducing the activities of voltage-activated Ca2+ channels, has no discernable effect on the 
efferent arteriole.11 
 
Molecular approaches confirmed that L-type Ca2+ channel protein is preferentially expressed 
in the afferent arteriole,12 but also suggested that additional species of voltage-activated Ca2+ 
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channels, including T- and N-type Ca2+ channels, might be expressed in the both vessel 
types.12-14  With the advent of pharmacologic agents capable of blocking such channels, it was 
subsequently shown that T/L-type channel blockers (e.g. mibefradil, efonidipine) reverse 
agonist-induced vasoconstriction of both afferent and efferent arterioles in contrast to 
dihydropyridines, which dilate only the afferent arteriole (reviewed in13).  Such observations 
have led to a prevailing view that both L- and T-type Ca2+ channels mediate signalling in the 
afferent arteriole and that T-type Ca2+ channels play an important role in the efferent arteriole.  
Nevertheless a number of facts are inconsistent with this premise.  These include the lack of 
effect of depolarization on the efferent arteriole,8-10 the ability of L-type selective 
dihydropyridines to fully block responses of the afferent arteriole13 and the low availability of 
T-type Ca2+ channels at physiologic membrane potentials of the unstimulated afferent and 
efferent arteriole in situt (-40 to -45 mV15).  In this regard, it is important to note that although 
these agents do block T-type Ca2+ channels they all have other actions that can affect vascular 
responses.   
 
Do T-type Ca2+ channels actually play an important role in the renal microcirculation or are 
the actions of these pharmacologic agents due to other reported effects?  These questions are 
critical in regard to our understanding of the control of the renal circulation and have 
important clinical implications.  For example, it has been suggested that because T-type Ca2+ 
channel blockers reverse efferent vasoconstriction, these agents are renal protective as 
compared to L-type Ca2+ blockers which by increasing PGC promote hypertensive injury.14   
These considerations point to importance of studies that directly evaluate the voltage-
activated Ca2+ channels that are present in the renal afferent and efferent arterioles using patch 
clamp.  To our knowledge the present study is the first to do so using single myocytes freshly 
dispersed from individually isolated afferent and efferent arterioles.       
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2. Methods 
 
All procedures complied with University of Calgary Animal Ethics and Canadian Council on 
Animal Care regulations and conformed with the Guide for the Care and Use of Laboratory 
Animals published by the US National Institutes of Health (NIH Publication, 8th Edition, 
2011). 
 
The characteristics of the Ca2+ channels present in native renal afferent (AA) and efferent 
(EA) arteriolar myocytes were evaluated using the whole-cell patch-clamp at room 
temperature (23ºC).  Individual renal arterioles were isolated from the renal cortex (excluding 
the juxtamedullary area) of normal male Sprague–Dawley rat kidneys using the gel-perfusion 
technique.8 Tissue was harvested under deep halothane anaesthesia (1.5-2% flow rate, 
assessed by the absence of paw withdrawal reflex) and animals were euthanized by 
exsanguination.  Only relaxed myocytes isolated from afferent and efferent arterioles as 
previously described8 were used in electrophysiological experiments. Myocytes from the rat 
tail artery (TA) were used as positive control, as both T- and L-type Ca2+ currents are 
consistently reported in these cells (e.g.16,17). TA myocytes were dispersed from the tissue 
with the enzyme solution containing 2mg/ml collagenase NB8, 200U/ml collagenolytic 
protease, 2mg/ml dispase II and 0.8U/ml elastase III (30-35min, 37ºC).  All types of isolated 
myocytes were studied under identical conditions.  Electrophysiological recordings were 
performed as described previously.18  Pipettes (resistance 6-12 MΩ) were filled with a 
solution containing (mmol/L): 120 Cs+-methansulfonate, 20 CsCl, 5 HEPES, 2 MgATP, 0.5 
Na2GTP, 5 EGTA, 0.3 MgCl2, pH=7.2.  The external bath solution contained (mmol/L): 140 
NaCl, 5 CsCl, 5 HEPES, 1 MgCl2, 5 glucose, pH=7.35.  Ca2+ (ICa) and Ba2+ (IBa) currents 
were studied in 1.5 mmol/L CaCl2 and 10 mmol/L BaCl2, respectively.  Current densities 
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were calculated by correcting for leak current (off-line) and then dividing by the cell 
capacitances (Cm).   
 
Current-voltage (I-V) relationships for ICa and IBa were recorded from a holding potential of -
80 mV to activate both the L- and T-type current components.  Half-activation voltage (Va) 
and the slope factor of activation (ka) were obtained from normalized whole-cell I-Vs fitted to 
the function: ((Vm-ER)*g)/(1+exp((Vm-Va)/ka)), where Vm is membrane potential; ER the 
apparent reversal potential and g is the scaling factor.  In 35 afferent myocytes, mean ER and g 
were 44±2 mV and 0.04±0.004 mV-1 (peak ICa) and 61±1 mV and 0.03±0.002 mV-1 (peak 
IBa), respectively.  In 32 TA myocytes, mean ER and g were 53±2 mV and 0.06±0.01 mV-1 
(peak ICa) and 60±2 mV and 0.02±0.001 mV-1 (peak IBa), respectively.  
 
Ca2+ channel availability was investigated by applying 500 ms conditioning voltages (VC) 
(between -80 to +40 mV in 10 mV increments) followed by a test pulse (0 or -20 mV).  
Current amplitudes at the test pulse were normalized and fit to a modified Boltzmann 
function: (1-A)/(1+exp((VC-Vh)/kh)), where Vh and kh are half-inactivation potential and the 
slope factor of inactivation, and A is non-inactivating component of the current.  
 
Data are expressed as the means using the standard error of the mean (s.e.m.).  Differences 
between means were evaluated by paired or unpaired Student's t test.  For multiple 
measurements, analysis of variance (ANOVA) followed by Bonferroni post-hoc test were 
applied to assess significance. Probabilities with p<0.05 were considered significant.
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3. Results 
 
At physiologic levels of extracellular Ca2+ (1.5 mmol/L), afferent arteriolar myocytes 
displayed a prominent ICa.  The inward current exhibited a threshold near -30 mV (Fig.1A and 
1C), typical of the L-type Ca2+ channels reported in other vascular smooth muscle cells 
(VSMCs).19  ICa reached maximum near 10 mV and had the mean peak amplitude of -8.9±1.3 
pA (n=36, Fig.1C).  The properties of these channels were further studied in the presence of 
extracellular 10 mmol/L Ba2+.  It has been previously demonstrated that the L-type IBa 
recorded in this concentration of Ba2+ is activated in a similar voltage range as ICa in 
physiological levels of calcium.19  Under these conditions, IBa reached its maximal at 20 mV 
and mean peak IBa was increased to 37.1±5.1 pA (n=36, Fig.1B and 1C).  The peak IBa 
significantly correlated with the size of afferent myocytes expressed as Cm (p=0.011).  As 
shown in figure 1D, peak ICa and IBa densities were -2±0.2 pA/pF and -7.3±0.8 pA/pF, 
respectively.  This ~3.6-fold increase in the current is typical for L-type Ca2+ channels.19,20  In 
this group of afferent myocytes, Cm ranged from 2.9 to 10.3 pF (mean 5.5±0.3 pF, n=36), 
being similar to 5.6±0.2 pF (range 2.2-11 pF) obtained in 125 myocytes isolated from 87 
afferent arterioles and 42 animals. 
 
Notably, no measurable whole-cell inward current was observed in afferent myocytes at 
membrane potentials negative to -30 mV in either Ba2+or Ca2+ (Fig.1D).  Moreover, the small 
ICa and IBa seen at -20 mV (grey tracings in figures 1A and 1B) did not exhibit temporal 
inactivation.  Both features are characteristics of the L- and not T-type Ca2+ channels.  To 
further pursue this issue, we applied the same approach to myocytes isolated from the rat tail 
artery (TA), a vessel known to express both the T- and L-type Ca2+ channels.16,17 
 
 at U
niversity of Bath on O
ctober 8, 2012
http://cardiovascres.oxfordjournals.org/
D
ow
nloaded from
 
A
cc
ep
te
d 
M
an
us
cr
ip
t
8 
Figure 2A shows representative IBa traces recorded from a TA myocyte using the same 
experimental protocol as shown in Fig.1.  Mean I-V data comparing IBa (filled squares) and ICa 
(open squares) densities recorded in 32 TA myocytes are depicted in figure 2B.  Although the 
general character of I-V curves for afferent and TA myocytes were similar, modest differences 
were discerned.  Firstly, the peak IBa density was significantly larger in the afferent myocytes 
(-7.3±0.8 pA/pF, n=36) compared to the TA myocytes (-2.7±0.2 pA/pF, n=32, p=0.00005), 
although TA myocytes (Cm=30.9±1.4 pF, n=32) were 5.5 times larger than afferent myocytes 
(Cm=5.5±0.3 pF, n=36).  Secondly, switching from Ca2+ to Ba+2 produced a small, albeit 
significant, shift in the half-activation potential (Va) of afferent arteriolar myocytes, whereas 
no such shift was detected in the TA myocytes (Fig.2C).  Although the Va for the whole-cell 
IBa of TA myocytes (0.8±0.4 mV) was significantly more negative than that of afferent 
myocytes (3.4±0.5 mV, p=0.0003) (Fig.2C), the difference was quite modest.  Accordingly, 
the presence of different Ca2+ channel types could not be clearly discerned based only on the 
difference in the activation of the composite whole-cell current as was demonstrated in some 
VSMCs.19-21  
 
In addition to a more negative Va, T-type Ca2+ currents exhibit rapid inactivation which is 
particularly prominent at negative voltages where the T-component of the current is prevailed 
over the L-component.  The comparison of the representative tracings depicted in grey in 
figures 1A and 2A illustrates that IBa at -20 mV decreases within a 100 ms depolarizing step in 
the TA myocyte, but not in the afferent myocytes.  To highlight this difference in the current 
kinetics, the mean ICa and IBa densities measured at -20 mV in afferent and TA myocytes 
(leak-corrected off-line) are compared in figures 2D and 2E, respectively.  Both ICa and IBa 
display prominent inactivation in TA myocytes, but not in afferent myocytes.  
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To further evaluate if the observed difference in the kinetics of IBa in afferent and TA 
myocytes represented differing contributions of T- and L-type channels, we used an 
availability protocol.  Figures 3A and 3C depict traces of IBa recorded at the test potential of 0 
mV following 0.5 s conditioning voltages between -80 and 40 mV for afferent and TA 
myocytes, respectively. When both L- and T-type Ca2+ channels are present, both currents 
will contribute to the initial peak of the whole-cell IBa.  At the end of 100 ms test pulse, 
however, the L-type current will dominate, as T-type channels are rapidly inactivated and 
their contribution to the whole-cell IBa will thus be diminished (as seen in Fig.2E).  Moreover, 
since L- and T-type channels exhibit marked differences in the voltage-dependency of 
inactivation with the T-type inactivating at more negative voltages than the L-type,17,19,22 the 
effects of depolarizing conditioning pulses on the peak IBa will differ from their effects on IBa 
measured at the end of the 100 ms test pulse, if both currents are present.  To evaluate this 
difference in afferent myocytes, the peak IBa and IBa measured at the end of 100 ms test pulse 
were normalized and fitted with a modified Boltzmann function in each cell and the mean 
values are compared in Figure 3B.  No significant differences in the half-inactivation potential 
(Vh), the slope factor of inactivation (kh) or the non-inactivating component (A) were observed 
(Vh=-14.6±2.9 mV, kh=9.2±1.4 mV, A=0.37±0.05 for peak IBa and Vh=-12.5±2 mV, 
kh=8.2±0.9 mV, A=0.35±0.04 for IBa at 100 ms, n=10). The lack of changes in the voltage-
dependent inactivation parameters was also associated with the absence of a substantial effect 
on IBa at the test step following by conditioning potentials between -80 and -20 mV (Fig.3A, 
the current at the conditioning potential -20 mV shown in grey). 
 
By contrast, TA myocytes subjected to the same protocol exhibited a significant leftward shift 
in the availability of the peak IBa (Vh=-23.1±1.6 mV) compared to that for IBa at 100 ms (Vh=-
10.7±1.1 mV, n=12, p=0.00002, Fig.3D).  Also, significant changes in ka (11.4±0.6 mV vs 
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8.7±0.7 mV, p=0.0033)) and in A (0.25±0.03 vs 0.36±0.03, p=0.00001) for the peak and 100 
ms IBa, respectively, were found.  These effects strongly suggest the presence of at least two 
current components in TA myocytes; with the peak IBa containing both the T- and L-
components whilst IBa at 100 ms is predominantly the L-type.  The similarity between the 
half-inactivation potential for IBa at 100 ms in TA myocytes and that for IBa measured both at 
the peak and 100 ms in afferent myocytes supports the dominance of the L-type in the latter 
(compare Fig.3B and 3D).  The analysis of IBa availability at -20 mV in TA myocytes 
(Fig.3D, filled triangles) where the T-component is dominant, shows even more striking 
difference with an over 30 mV negative shift in the availability (Vh=-43.4±1.3 mV, 
kh=5.6±1.3 mV, A=0.36±0.04, n=9) compared to that for IBa measured at 100 ms at 0 mV.  
The size of IBa at -20 mV in afferent myocytes was too small to derive meaningful availability 
dependence using this approach.  
 
The presence of the fast inactivating T-type component can also be demonstrated by the 
analysis illustrated in figure 3E.  These data depict difference currents obtained by subtracting 
IBa at the test potential 0 mV following a conditioning step to -20 mV (when the current is 
predominantly L-type since the T-type is inactivated as illustrated in Fig.3D) from that 
obtained after a conditioning step to -80 (when both currents are available).  As shown in 
figure 3E, a fast-inactivating T-type current is readily demonstrated in the TA myocytes but 
not in afferent myocytes. The non-inactivating difference current in both cell types is due to 
the partial inactivation of L-type channels at -20 mV (Fig.3B and 3D).  Furthermore, the 
analysis of the current kinetics of the mean IBa densities measured at 500 ms conditioning 
prepulses to physiologically relevant voltages of -40, -30 and -20 mV in afferent (left) and TA 
(right) myocytes in figure 3F clearly demonstrates fast inactivating kinetics of IBa, a 
characteristic property of the T-type current,  in TA, but not in afferent, myocytes.  
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We next examined the effects of nifedipine, a selective L-type Ca2+ channel blocker.  Figures 
4A and 4C compare the effect of 1 µmol/L nifedipine on the mean IBa recorded at -20 mV, 
while figures 4B and 4D compares the mean I-Vs in afferent (n=10) and TA (n=13) myocytes. 
Note that in the afferent myocytes, nifedipine significantly eliminated IBa inhibiting the 
current by 75±7% (p=0.007). In comparison, in TA myocytes the block of IBa at -20 mV to 
nifedipine (Fig.4C) was significantly less (27±4%, p=0.000005).  Moreover, the full I-V plot 
of TA myocytes (Fig.4D) revealed a significant blockade at more positive potentials, but 
clearly exhibited a component of the nifedipine-insensitive voltage-activated inward current.  
A comparison of the steady-state half-activation parameters disclosed a significant nifedipine-
induced leftward shift in Va in TA myocytes, but not in afferent myocytes (Fig.4E).  We were 
able to conduct the availability at 0 mV test potentials in two nifedipine-treated TA myocytes 
and found Vh to be -38.9 and -37.5 mV, values similar to those seen in the absence of 
nifedipine at test potentials of -20 mV (Fig.3D).  
 
Figure 5 illustrates the effects of 200 nmol/L kurtoxin, a selective inhibitor of T-type Ca2+ 
channels, on afferent (A-D) and TA (E-H) myocytes.  IBa was monitored using repeated 100 
ms steps from a holding potential of -80 mV to 0 mV, during control periods and following 
application of kurtoxin.  Figures 5A and 5E depict representative control tracings and tracings 
obtained after 5 minutes treatment in kurtoxin in the two cell types.  In the afferent myocyte 
kurtoxin caused a small but similar decrease in both the peak and IBa at 100 ms (Fig.5A), 
whereas in the TA myocyte the inhibitor completely blocked an initial rapidly inactivating 
component of IBa but had little effect on IBa at the end of step depolarization (Fig.5E).  Figures 
5B and 5F compare the mean kurtoxin-sensitive currents (control minus kurtoxin-treated) and 
the mean control difference currents (control minus time controls without kurtoxin) in afferent 
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and TA myocytes, respectively illustrating the effects of kurtoxin and current run-down.  
Note, that an inactivating, kurtoxin-sensitive current was evident in the myocytes from TA, 
but not in myocytes from the afferent arteriole. Figures 5C and 5G depict the time-dependent 
effects of kurtoxin on the initial peak IBa in both cell types, whereas figures 5D and 5H show 
its effect on the currents measured at 100 ms.  To account for run down, data from time 
controls (n=4-5) in which measurements were made in the absence of kurtoxin are depicted as 
filled symbols in these figures.  In TA myocytes, kurtoxin significantly suppressed the peak 
current by 36.8±6.6% (p=0.005, Fig.5G), whereas the effect was seen on IBa at the end of 100 
ms was indistinguishable from the time controls (Fig.5H).  No significant effects of kurtoxin 
were observed on either peak or 100 ms IBa in afferent myocytes (Fig.5C and 5D).   
 
The efferent arteriole is an unusual blood vessel, in that contractile responses are not affected 
by selective L-type Ca2+ channel blockers4,23 or by hyperpolarization.11 Similarly, 
depolarization has no effect on tone or calcium entry in this vessel.8-10  Conversely, based on 
responses to non-selective agents that preferentially block T-type channels, it has been 
suggested that T-type Ca2+ channels contribute to the activation of the efferent arteriole.13,23-25  
In this study we were able to obtain the first measurements of ICa and IBa in myocytes from 
isolated efferent arterioles.  We could not, however, maintain the whole-cell access long 
enough statistically compare full I-Vs in both conditions as in afferent myocytes.  Therefore, 
the whole-cell currents were compared at a test potential to 0 mV.  The current traces were 
leak-subtracted off-line, corrected for the cell size, averaged and compared in Fig.6 with the 
currents in afferent myocytes recorded under identical conditions.  In 1.5 mmol/L Ca2+ no 
measurable inward current was detected in efferent myocytes (Figs.6A and 6B).  With barium 
as the charge carrier, a small inward current was observed (Fig.6C).  However, similar to ICa, 
it was significantly smaller compared to the afferent myocytes (-0.5±0.4 pA/pF, n=5, vs. -
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3.5±0.4 pA/pF, n=36)(Fig.6D).  Notably, as in afferent myocytes, the small IBa seen in 
efferent myocytes did not display time dependent inactivation (Fig.6C).  
 
4. Discussion 
 
The present study is the first to demonstrate and characterize voltage-activated Ca2+ channel 
currents in myocytes isolated from native afferent and efferent arterioles using direct patch-
clamp techniques.  Afferent arteriolar myocytes exhibited a relatively high density of L-type 
Ca2+ currents and these currents could readily be measured in physiologic Ca2+.  By contrast, 
efferent myocytes did not exhibit a measurable voltage-activated inward current under 
physiologic Ca2+ conditions.  These differences are unlikely due to difference in cell size and 
different rate of cell dialysis as the cell size (measured as Cm) was similar in both types of 
arterioles but was 5-fold less than that of TA myocytes which had significantly smaller ICa 
and IBa density then AA myocytes. We could not demonstrate the presence of a measurable T-
type Ca2+ current in myocytes from either the afferent or efferent arteriole.  These findings 
support the results of previous studies demonstrating the differing sensitivities of the afferent 
and efferent arterioles to specific L-type Ca2+ channel blocking agents.3-6,26   
 
Conversely, our findings do not support the premise that T-type Ca2+ channels directly 
contribute to the activation of either vessel.  A number of laboratories have demonstrated that 
non-selective T-type channel inhibitors such as mibefradil, efonidipine or pimozide are 
capable of blocking contractile responses of both afferent and efferent arterioles (see 
review13) and it is suggested that these channels contribute to the activation of both vessels.  It 
must be emphasized, however, that this premise is supported by indirect observations and 
relies exclusively on contractile responses.  In contrast, our conclusions are based on the 
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direct measurements of Ca2+ channel currents in single myocytes.  Nevertheless, when 
comparing the results between the intact preparations and enzymatically isolated cells, one 
could question whether ion channels remain intact in isolated myocytes.  To address this 
possibility, we conducted parallel studies in myocytes isolated from the rat TA using the same 
cocktail of enzymes. Although the function of the rat tail artery differs from that of the renal 
arterioles, TA myocytes are the only vascular cell type where the presence of both L- and T-
type currents have been consistently documented,16,17 thus this tissue represented a critical 
positive control. Another important argument could be that expression of functional Ca2+ 
channels varies between different cells. For example, previous studies found T-type currents 
only in limited number of VSMCs isolated from the same vessel,16,17,19 including conduit 
vessels of the kidney.21 To address this concern, all myocytes isolated from TA and afferent 
arterioles and studied with the same protocol were included in our comparative analysis in 
contrast to previous studies in which exemplary cells expressing either T- or L-type currents 
were normally compared. 
 
The electrophysiological and pharmacological approaches we used were sufficient to 
demonstrate the presence of both T- and L-type Ca2+ currents in myocytes isolated from the 
rat tail artery, but not in similarly treated populations of afferent myocytes. Using the key 
biophysical properties of the T-type Ca2+ channels, such as fast inactivating kinetics and more 
negative voltage range of their activation and inactivation, our analysis clearly demonstrates 
the presence of all these features in TA myocytes, but not in afferent myocytes (Figures 2-3). 
The electrophysiological evidence is fully supported by the pharmacological separation of the 
two type Ca2+ currents in TA myocytes using the selective L-type Ca2+ channel inhibitor 
nifedipine and a relatively selective T-type blocker kurtoxin which at 200 nmol/L does not 
significantly affect the L-type currents27 (Figures 4-5). Furthermore, a significant leftward 
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shift in the steady-state activation dependency for IBa remaining in 1 µmol/L nifedipine in TA, 
but not in afferent, myocytes (Fig.4E) provides further argument against the presence of the 
T-type currents in the renal afferent myocytes.  
 
Although we did not observe T-type Ca2+ currents in these vessels, the expression of the 
CaV3.1 and CaV3.2 genes of the T-type Ca2+ channels has been demonstrated in the rat renal 
afferent arterioles isolated from the superficial regions of the renal cortex or from 
juxtamedullary nephrons and in the outer medullary vasa recta.12 We, therefore, cannot rule 
out the presence of a small, beyond the electrophysiological detection level, T-type current in 
the afferent arteriole. However, it would be difficult to directly compare protein expression 
between the two cell types using immunocytochemistry without understanding molecular 
nature of the T-type Ca2+ channels in TA myocytes which has not been established, and is 
outside the scope of this study. Furthermore, immunocytochemical analysis using antiCaV3.1, 
antiCaV3.2 and antiCaV3.3 antibodies in vascular SMCs has proven to be inconclusive.28,29 
Functionally, we found that the  L-type Ca2+ current is rather prominent in afferent arteriolar 
myocytes with the peak ICa density measured at physiologic Ca2+ was approximately twice 
that of TA myocytes (Figures 1-2). The size of the current in TA myocytes is comparable to 
that recorded in other types of arterial myocytes at physiologic levels of Ca2+.19,30,31 Similarly, 
the presence of L-type, but absence of detectable T-type Ca2+ currents has also been reported 
in smooth muscle like vasa recta pericytes.32 Based on our experimental evidence, we 
therefore suggest that L-type Ca2+ channels contribute more importantly to depolarization-
induced activation of these vessels. This view is also consistent with the observation that 
contractile responses and depolarization-induced Ca2+ signalling and Ca2+ influx of the 
afferent arteriole are completely blocked by selective L-type antagonists.4,8,23 
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We did not observe a significant voltage-activated inward current in efferent arteriolar 
myocytes in physiologic Ca2+, although minute IBa (~7 fold smaller than in afferent myocytes) 
was detected (Fig.6). This finding is consistent with the lack of effect of potassium-induced 
depolarization on tone9,10 and ineffectiveness of selective L-type blockers on this vessel4 as 
well as with the lack of their effect on intracellular [Ca2+] or Ca2+ influx8. Also, no L-type 
protein was detected in cortical efferent arterioles.12 One can only speculate on the nature of 
the Ca2+ entry in the efferent arteriole. Previous studies have shown that, unlike the afferent 
arteriole, angiotensin II-induced vasoconstriction in the efferent arteriole is not dependent on 
membrane depolarization.15 Moreover, using the fura-2/manganese quench technique, we 
have previously shown that angiotensin II activates a voltage-independent and nifedipine-
insensitive Ca2+ entry in this vessel.8 The molecular mechanisms and the type(s) of ion 
channels involved are however not known and require further focused studies.  
 
In the mouse conversely to the rat, Poulsen and co-workers recently reported that potassium-
induced depolarization elicits a transient vasoconstriction in isolated efferent arterioles.7 Since 
our studies and those cited above were conducted using rat arterioles, the possibility of 
species differences in the expression of Ca2+ channels in the efferent arteriole cannot be ruled 
out. We also cannot exclude a possibility that afferent and efferent arterioles from 
juxtamedullary nephrons may express L- and T-type channels in different proportions 
compared to the superficial cortical arterioles studied in this paper, thus explaining a greater 
sensitivity of perfused juxtamedullary arterioles to non-specific T-type channel blockers like 
mibefradil or pimozide.24 Alternatively, the action of at least some inhibitors may be 
explained by their action elsewhere due to their lack of specificity via, for example, effects on 
endothelial channels.33,34 To our knowledge, the renal microvascular effects of kurtoxin, 
which is considered to be the most specific T-type Ca2+ channel blocker as our study also 
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suggests, have not been investigated. Accordingly, the possibility that these agents affect the 
renal microcirculation by actions other than T-type Ca2+ channel blockade also merits 
consideration. A final resolution of this issue awaits further investigations. 
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Figure Legends: 
 
Figure 1. Calcium channel currents in renal afferent arteriolar myocytes. (A) and (B) Whole-
cell inward currents recorded from a representative cell in the presence of 1.5 mmol/L Ca2+ 
and 10 mmol/L Ba2+, respectively. Traces in grey show currents at -20 mV. Cm=3.1 pF. (C) 
and (D) Comparison of I-V relationships for the peak (C) and the leak-subtracted densities (D) 
for ICa () and IBa (), n=36. 
 
Figure 2. Comparison of Ca2+ channel currents in single renal afferent and TA myocytes. (A) 
IBa recorded from a representative TA myocyte in 10 mmol/L Ba2+. Trace in grey shows IBa at 
-20 mV. Cm=33.1 pF. (B) I-V relationships for the leak-subtracted peak ICa () and IBa () 
densities in rat tail arterial myocytes, n=32. (C) Changes in the mean half-activation potential 
for ICa and IBa in the two cell types (for renal afferent arteriole, n=35; for TA, n=32; see 
Methods for further details). (D) and (E) Comparison of the mean ICa and IBa, respectively, 
recorded at -20 mV in renal afferent arteriolar (n=38-39) and TA (n=33) myocytes. Currents 
were leak-corrected off-line, grey lines show s.e.m.  
 
Figure 3. Differences in IBa inactivation in myocytes from the renal afferent arteriole and tail 
artery.  (A) and (C) Current traces from a representative renal afferent and TA myocyte, 
respectively. Traces in grey show current at -20 mV. Cm=30.5 pF. (B) and (D) Normalized 
availabilities for the peak IBa (,) and the current at the end of 100 ms test pulse (,) in 
afferent (n=10) and TA (n=12) myocytes, respectively. Filled triangles show availability for 
the peak IBa recorded at the test potential of -20 mV in TA myocytes where the T-type 
component was predominant (n=9). Solid lines are theoretical approximation to the modified 
Boltzmann equation as described in Methods and in the text. Dashed lines show half-
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inactivation potentials. (E) Comparison of the mean voltage-sensitive IBa calculated as the 
difference current at the test potential 0 mV measured following conditioning potentials to -80 
and -20 mV and expressed as current densities. (F) Comparison of the mean IBa densities at 
negative membrane voltages during a prolonged 500 ms depolarization in the renal afferent 
arteriolar (left, n=10) and TA (right, n=12) myocytes. 
 
Figure 4. Effect of the nifedipine on IBa in renal afferent (A-B) and TA (C-D) myocytes. (A) 
and (C) Mean IBa density at -20 mV before (Control) and in the presence of 1 µmol/L 
nifedipine in afferent (n=10) and TA (n=13) myocytes, respectively. (B) and (D) Normalized 
I-V in the absence (open symbols) and presence (closed symbols) of nifedipine.  (E) Diverge 
effect of nifedipine on the Ca2+ channel activation in TA (n=13) and renal afferent (n=7; in 3 
cells IBa in the presence of nifedipine was too small to be theoretically approximated) 
myocytes. 
 
Figure 5. Comparison of the effect of the T-type Ca2+ channel inhibitor kurtoxin on IBa in 
renal afferent (A-D) and tail arterial (E-H) myocytes. (A) and (E) IBa at 0 mV before (Control) 
and 5 min after addition of 200 nmol/L kurtoxin in a representative renal afferent arteriolar 
(Cm=4.5 pF) and tail arterial (Cm=38.6 pF) myocyte, respectively. (B) and (F) Mean kurtoxin-
sensitive IBa (derived as a difference between IBa before and 5 min after addition of kurtoxin 
in each cell, n=5 for both cell types) and mean control difference IBa (calculated at the same 
time points as for kurtoxin but in the absence of the blocker in 4 afferent and 6 tail arterial 
myocytes), respectively. Grey lines show s.e.m. (C-D) and (G-H) Comparison of the time-
dependence of the current block measured at the peak (10-12 ms, C and G) and at the end of 
100 ms (D and H) voltage step to 0 mV. Kurtoxin was applied at time 0 for 5 min (filled 
symbols). Open symbols show time control run in the absence of the inhibitor, n=4-6. 
 at U
niversity of Bath on O
ctober 8, 2012
http://cardiovascres.oxfordjournals.org/
D
ow
nloaded from
 
A
cc
ep
te
d 
M
an
us
cr
ip
t
23 
 
Figure 6. Calcium channel currents in rat renal efferent arterioles. (A) and (C) Comparison of 
the mean ICa and IBa densities recorded at 0 mV in myocytes isolated from efferent and 
afferent arterioles as indicated. Grey lines show s.e.m. (B) and (D) Statistical comparison of 
the peak densities for ICa and IBa, respectively, in the efferent and afferent myocytes. 
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